HIF1A and neoplasm: ESM1 promotes angiogenesis and tumor progression in CRC through activation of the PI3K/Akt/mTOR signaling pathway and upregulation of pro-angiogenic and inflammatory factors such as VEGF, COX-2, and HIF-1α [31].